The other problem is that despite spending significantly more than any other nation, measures of health care (i.e preventable deaths, access to health care) rank the US well behind other first world nations.
The interview largely ignores that concern, and focuses instead on the strawman of absolute cost.
Unfortunately the debate usually isn't as black and white all the time given that there are a number of metrics like survival rates following heart attacks or cancer detection/treatment where the US is very much ahead of other first world nations.
Absolute cost is far from a strawman in this issue given that the basic argument for reform (as they've proposed - since I think a lot of people are for reform including Dean Kamen), is that the US healthcare system as it is now is too expensive and ergo a significant barrier to access. Others like Kamen make the point that by restricting absolute costs, innovation will drop because the incentives for innovating drop.
